The independent source for health policy research, polling, and news.
Showing 141 - 160 of 259
The survey also found public support for program changes that would place work requirements on beneficiaries and make drug testing a condition of enrollment.
Critics point to the state’s aggressive eligibility checks as an example of what can go wrong when states have flexibility and add a reason to worry about GOP efforts to overhaul the program.
The North Carolina Harm Reduction Coalition has advanced a local shift from a tough-on-drugs approach to harm-reduction philosophy. Other red states signal they may follow suit.
A study in Health Affairs shows that people who receive federal housing vouchers and other forms of public housing assistance are more likely to have health insurance and get regular medical care.
The Zika virus, which made its appearance in the U.S. last summer, is still not well understood, and federal and state officials are not sure what to expect this year.
Local health officials are bracing for the potential impact of a Trump administration policy that would stop federal funding to jurisdictions that don’t enforce federal immigration laws.
Even as drug pricing issues continue to draw scrutiny, federal safety regulations and incentives offer drug companies a new avenue to get a sweet return on their development costs.
Researchers concluded that because the federal government picked up so much of the tab of expanding eligibility for the low-income insurance program, expansion states didn’t have to skimp on other policy priorities to make ends meet.
These workers, who generally do not get health insurance from their employers and fall through public assistance coverage gaps, gained some relief under Obamacare.
Research published today suggests childhood lead exposure, which affects half a million children and which the CDC has been deemed a major public concern, doesn’t just impact cognitive development but also undermines class mobility.
A provision in the 2010 health law required these hospitals to justify their tax exemption by demonstrating involvement in community health. Repeal, replace or repair could stall that momentum.
Epinephrine, the active ingredient in EpiPens, expires after 18 months, and the auto-injector device can’t be refilled or reused. Health professionals are looking for work-arounds they say could save the health system millions.
Aetna will be the third major insurer to remove prior authorization requirements for patients who seek medication-assisted treatments such as Suboxone.
In an interview with Kaiser Health News, Michael Botticelli outlines his concerns about how GOP efforts to dismantle the health law’s coverage expansions could jeopardize treatment for people in need.
The device, known as Evzio, administers just enough naloxone to stabilize someone who has overdosed on drugs. But its manufacturer, Kaleo, may be positioning itself to find profits in a dire health care crisis.
Republican plans to transform Medicaid could help set debate on the role of government and entitlements. Here's an explanation of how it could work.
New research finds that the Affordable Care Act — especially the Medicaid expansion — helped about 4 million people with chronic health problems get coverage. Researchers say their findings could help Republicans planning a replacement.
The Affordable Care Act, which President-elect Donald Trump has vowed to repeal, threw a number of life-savers to rural hospitals, which are vital but financially troubled centers. And its full repeal, without a comparable and viable replacement, could signal their death knell.
Two studies quantify gains made as a result of the Affordable Care Act’s Medicaid expansion and fuel concerns about how GOP plans to repeal and replace it might undermine these advances.
Older patients who were treated in the hospital by women physicians were less likely to die or be readmitted to the hospital within 30 days of discharge, according to a new study.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF